Literature DB >> 21997606

Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium.

Silvia Bazzini1, Claudia Udine, Giovanna Riccardi.   

Abstract

Burkholderia cenocepacia is a Gram-negative opportunistic pathogen belonging to the Burkholderia cepacia complex (Bcc). It is spread in a wide range of ecological niches, and in cystic fibrosis patients, it is responsible for serious infections. Its eradication is very difficult due to the high level of intrinsic resistance to clinically relevant antibiotics. One of the main resistance mechanisms in clinical isolates is represented by efflux systems that are able to extrude a variety of molecules, such as antibiotics, out of the cell. Resistance-Nodulation-Cell Division (RND) efflux pumps are known to be mediators of multidrug resistance in Gram-negative bacteria. Since now, the significance of the RND efflux systems in B. cenocepacia has been partially determined. However, the analysis of the completely sequenced genome of B. cenocepacia J2315 allowed the identification of 16 operons coding for these transporters. We focused our attention on the role of these pumps through the construction of several deletion mutants. Since manipulating B. cenocepacia J2315 genome is difficult, we used a peculiar inactivation system, which enables different deletions in the same strain. The characterization of our mutants through transcriptome and phenotype microarray analysis suggested that RND efflux pumps can be involved not only in drug resistance but also in pathways important for the pathogenesis of this microorganism. The aim of this review is an updated overview on host-pathogen interactions and drug resistance, particularly focused on RND-mediated efflux mechanisms, highlighting the importance of molecular techniques in the study of B. cenocepacia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997606     DOI: 10.1007/s00253-011-3616-5

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  9 in total

1.  Draft genome sequence of the volatile organic compound-producing Antarctic bacterium Arthrobacter sp. strain TB23, able to inhibit cystic fibrosis pathogens belonging to the Burkholderia cepacia complex.

Authors:  Marco Fondi; Valerio Orlandini; Isabel Maida; Elena Perrin; Maria Cristiana Papaleo; Giovanni Emiliani; Donatella de Pascale; Ermenegilda Parrilli; Maria Luisa Tutino; Luigi Michaud; Angelina Lo Giudice; Renato Fani
Journal:  J Bacteriol       Date:  2012-11       Impact factor: 3.490

2.  MtvR is a global small noncoding regulatory RNA in Burkholderia cenocepacia.

Authors:  Christian G Ramos; André M Grilo; Paulo J P da Costa; Joana R Feliciano; Jorge H Leitão
Journal:  J Bacteriol       Date:  2013-05-31       Impact factor: 3.490

3.  Activator of G-Protein Signaling 3-Induced Lysosomal Biogenesis Limits Macrophage Intracellular Bacterial Infection.

Authors:  Ali Vural; Souhaila Al-Khodor; Gordon Y C Cheung; Chong-Shan Shi; Lalitha Srinivasan; Travis J McQuiston; Il-Young Hwang; Anthony J Yeh; Joe B Blumer; Volker Briken; Peter R Williamson; Michael Otto; Iain D C Fraser; John H Kehrl
Journal:  J Immunol       Date:  2015-12-14       Impact factor: 5.422

4.  Efflux pump-mediated drug resistance in Burkholderia.

Authors:  Nicole L Podnecky; Katherine A Rhodes; Herbert P Schweizer
Journal:  Front Microbiol       Date:  2015-04-14       Impact factor: 5.640

5.  Identification of new sphingomyelinases D in pathogenic fungi and other pathogenic organisms.

Authors:  Camila Dias-Lopes; Izabella A P Neshich; Goran Neshich; José Miguel Ortega; Claude Granier; Carlos Chávez-Olortegui; Franck Molina; Liza Felicori
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

6.  Linking Bacterial Endophytic Communities to Essential Oils: Clues from Lavandula angustifolia Mill.

Authors:  Giovanni Emiliani; Alessio Mengoni; Isabel Maida; Elena Perrin; Carolina Chiellini; Marco Fondi; Eugenia Gallo; Luigi Gori; Valentina Maggini; Alfredo Vannacci; Sauro Biffi; Fabio Firenzuoli; Renato Fani
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-26       Impact factor: 2.629

7.  Investigating the Role of the Host Multidrug Resistance Associated Protein Transporter Family in Burkholderia cepacia Complex Pathogenicity Using a Caenorhabditis elegans Infection Model.

Authors:  Pietro Tedesco; Marco Visone; Ermenegilda Parrilli; Maria Luisa Tutino; Elena Perrin; Isabel Maida; Renato Fani; Francesco Ballestriero; Radleigh Santos; Clemencia Pinilla; Elia Di Schiavi; George Tegos; Donatella de Pascale
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

Review 8.  Burkholderia cepacia Complex Vaccines: Where Do We Go from here?

Authors:  Gonzalo A Pradenas; Brittany N Ross; Alfredo G Torres
Journal:  Vaccines (Basel)       Date:  2016-04-15

9.  Comparative Genomics of Environmental and Clinical Burkholderia cenocepacia Strains Closely Related to the Highly Transmissible Epidemic ET12 Lineage.

Authors:  Josselin Bodilis; Elodie Denet; Elisabeth Brothier; Arnault Graindorge; Sabine Favre-Bonté; Sylvie Nazaret
Journal:  Front Microbiol       Date:  2018-03-06       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.